CN Stock MarketDetailed Quotes

600223 Lushang Freda Pharmaceutical

Watchlist
  • 8.74
  • -0.05-0.57%
Market Closed May 10 15:00 CST
8.88BMarket Cap38.17P/E (TTM)

About Lushang Freda Pharmaceutical Company

The company is a listed company controlled by Shandong Commercial Group Co., Ltd. (stock code: 600223). Lushang Development will adhere to the “healthy life service provider” position, focus on the three major business chains of “healthy city construction ecological chain, biomedical product chain, and health management service chain” to create a brand service with “full coverage of healthy life, full improvement of health quality, and full optimization of health experience” for customers, and is committed to growing into a comprehensive healthy life service group integrating science, industry and trade, industry, education and research. The main business covers business segments such as pharmaceuticals, cosmetics, raw materials and additives. Corporate honors: Heze City's Top 20 Real Estate Development Enterprises with Comprehensive Strength, AAA Enterprise Credit Rating Enterprise, Double Top 10 Enterprise, “Golden Round Table Award” of the 12th China Listed Company Board of Directors, Comprehensive Credit Green Card Enterprise, etc.

Company Profile

Short Name-A福瑞达
Symbol-A600223
Company NameLushang Freda Pharmaceutical Co.,Ltd.
Listing DateJan 13, 2000
Issue Price6.80
Shares Offered110.00M share(s)
FoundedApr 21, 1993
Listed ExchangeSH Stock Exchange
Legal Representativeqingwen jia
CEOchunmingdai gao
Secretaryhongyang zhang
Accounting FirmShanghui Accounting Firm (special general partnership)
Securities Representativeweiyu dai
Legal CounselGuo Hao Law Firm (Jinan)
Employees100
Phone0531-66699999
Office AddressNo. 888 Xinluo Street, High-tech Zone, Jinan City, Shandong Province
Zip Code250101
Registered AddressBoshan Economic Development Zone, Zibo City, Shandong Province
Fax0531-66697128
Emaillsfrd600223@163.com
Business License370000018020768
BusinessGeneral projects: medical research and experimental development; cosmetics retail; cosmetics wholesale; manufacture of biobased materials; sales of biobased materials; research and development of biobased materials technology; internet sales (except for the sale of goods requiring a license); biochemical product technology research and development; technical services, technology development, technology consulting, technical communication, technology transfer, technology promotion; health consulting services (excluding medical services); old-age services; nursing institution services (excluding medical services); investment activities with own funds. (Except for projects subject to approval according to law, independent business activities are carried out with a business license) Permitted projects: pharmaceutical production; drug wholesale; pharmaceutical Internet information services; drug contract production; drug import and export; pharmaceutical retail; and cosmetics production. (For projects requiring approval according to law, business activities can only be carried out after approval by the relevant departments; specific business projects are subject to the approval documents or licenses of the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • qingwen jia
  • Chairman,directors
  • 1.16M
  • ming zhou
  • directors
  • --
  • yuhai su
  • Independent directors
  • 100.00K
  • desheng zhu
  • Independent directors
  • 100.00K
  • dong duan
  • Outside directors
  • --
  • hongyang zhang
  • Board Secretary,Deputy General Manager
  • 95.80K
  • weiyu dai
  • Securities affairs representative
  • --
  • yuanzhong lv
  • Chairman of the Supervisory Board,Shareholder Supervisors
  • --
  • ruiping cha
  • Shareholder Supervisors
  • --
  • wei yin
  • Deputy General Manager
  • 919.80K
  • qianqian dou
  • Deputy General Manager
  • 95.80K
  • deqiang zheng
  • Deputy General Manager
  • 95.80K
  • chunming gao
  • Deputy General Manager,Acting general manager
  • 95.80K
  • jian zhang
  • Executive Deputy General Manager
  • 667.60K
  • baiqiang xu
  • Chief Financial Officer
  • 95.80K
  • xiaomin cheng
  • Chief Development Officer
  • 1.28M
  • ze wang
  • Employee supervisors
  • 322.70K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg